We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Novel IVD Assay Tested for Heparin-Induced Thrombocytopenia

By LabMedica International staff writers
Posted on 31 Mar 2014
Print article
Image: The Fluorescent activated cell sorter FACSCalibur (Photo courtesy of BD Bioscience).
Image: The Fluorescent activated cell sorter FACSCalibur (Photo courtesy of BD Bioscience).
Laboratory tests to support clinical diagnosis of heparin-induced thrombocytopenia (HIT) are subdivided into functional, platelet activation assays that lack standardization, or immunological assays, which have moderate specificity toward HIT.

HIT is caused by the interaction of platelet-activating antibodies of immunoglobulin G (IgG) class with large complexes of platelet factor 4 (PF4) bound to heparin on platelets, resulting in platelet activation and subsequent triggering of the coagulation pathway.

Hematologists at the Institute for Clinical Transfusion Medicine and Children Hospital (Braunschweig, Germany) and an international team of scientists, monitored 346 patients with suspected HIT. From each patient, citrated platelet-poor plasmas (PPP) and sera was obtained. Patient sera were analyzed with PF4 IgG enzyme-linked immunosorbent assay (ELISA) or by Particle Gel Immuno Assay (PaGIA).

These assays were compared with the HITAlert Kit (IQ Products; Groningen, The Netherlands) where samples were measured and analyzed on standard flow cytometers, such as the FACS Calibur (BD Bioscience; Franklin Lakes, NJ, USA) capable of detecting fluorescein isothiocyanate (FITC) and R-Phycoerythrin (R-PE) fluorescence. HITAlert showed high sensitivity (88.2%) and specificity (99.1%) when compared with clinical diagnosis. Agreement of HITAlert with PF4 ELISA- and PF4 PaGIA-positive patients is low (52.7 and 23.2%, respectively), while agreement with PF4 IgG ELISA- and PF4 PaGIA-negative patients is very high (98.1 and 99.1%, respectively).

The authors concluded that the HITAlert assay showed good performance towards HIT diagnosis. Whether applying this functional test upfront makes immunoassays redundant is a question that depends on local logistic and diagnostic equipment, such as the availability of flow cytometry and fresh platelets. The data presented suggests that such an approach is possible. HITAlert is reliable, easy to perform, rapid, and standardized as an in vitro diagnostic product (IVD-registered in Europe) for clinical practice. These properties make HITAlert very suitable for rapid testing of platelet activation due to heparin therapy, but also for testing platelet-activating properties of alternative coagulants. Future studies should further unravel HITAlert performance in patient groups with heparin-independent platelet activation events, including antiphospholipid syndrome (APS) patients and patients undergoing orthopedic surgery. The study was published in the April 2014 issue of the International Journal of Laboratory Hematology.

Related Links:

Institute for Clinical Transfusion Medicine and Children Hospital
IQ Products
BD Bioscience


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.